
ID: g81ylcxq,
Text: structure based design of prefusion stabilized sars cov spikes the covid pandemic caused by the novel coronavirus sars cov has led to accelerated efforts to develop therapeutics diagnostics and vaccines to mitigate this public health emergency a key target of these efforts is the spike s protein a large trimeric class i fusion protein that is metastable and difficult to produce recombinantly in large quantities here we designed and expressed over structure guided spike variants based upon a previously determined cryo em structure of the prefusion sars cov spike biochemical biophysical and structural characterization of these variants identified numerous individual substitutions that increased protein yields and stability the best variant hexapro has six beneficial proline substitutions leading to fold higher expression than its parental construct and is able to withstand heat stress storage at room temperature and multiple freeze thaws a å resolution cryo em structure of hexapro confirmed that it retains the prefusion spike conformation high yield production of a stabilized prefusion spike protein will accelerate the development of vaccines and serological diagnostics for sars cov

ID: alrbutoy,
Text: genetic variants in tmprss and structure of sars cov spike glycoprotein and tmprss complex sars cov a highly transmittable pathogen has infected over million people around the globe the spike glycoprotein of sars cov engages host ace for adhesion tmprss for activation and entry with the aid of whole exome sequencing we report a variant rs in tmprss gene and its mutant v m which might impede viral entry furthermore we identified tmprss cleavage sites in s domain of spike glycoprotein and report the structure of tmprss in complex with spike glycoprotein we also report the structures of protease inhibitors in complex with tmprss which could hamper the interaction with spike protein these findings advance our understanding on the role of tmprss and in the development of potential therapeutics

ID: yjsxen4d,
Text: unexpected free fatty acid binding pocket in the cryo em structure of sars cov spike protein covid caused by severe acute respiratory syndrome coronavirus sars cov represents a global crisis key to sars cov therapeutic development is unraveling the mechanisms driving high infectivity broad tissue tropism and severe pathology our cryo em structure of sars cov spike s glycoprotein reveals that the receptor binding domains rbds tightly and specifically bind the essential free fatty acid ffa linoleic acid la in three composite binding pockets the pocket also appears to be present in the highly pathogenic coronaviruses sars cov and mers cov lipid metabolome remodeling is a key feature of coronavirus infection with la at its core la metabolic pathways are central to inflammation immune modulation and membrane fluidity our structure directly links la and s setting the stage for interventions targeting la binding and metabolic remodeling by sars cov one sentence summary a direct structural link between sars cov spike and linoleic acid a key molecule in inflammation immune modulation and membrane fluidity

ID: 34ljq0qt,
Text: structural basis of sars cov spike protein priming by tmprss entry of sars cov etiological agent of covid in the host cell is driven by the interaction of its spike protein with human ace receptor and a serine protease tmprss although complex between sars cov spike protein and ace has been structurally resolved the molecular details of the sars cov and tmprss complex are still elusive tmprss is responsible for priming of the viral spike protein that entails cleavage of the spike protein at two potential sites arg ser and arg ser the present study aims to investigate the conformational details of complex between tmprss and sars cov spike protein in order to discern the finer details of the priming of viral spike and to point candidate drug targets briefly full length structural model of tmprss was developed and docked against the resolved structure of sars cov spike protein with directional restraints of both cleavage sites the docking simulations showed that tmprss interacts with the two different loops of sars cov spike protein each containing different cleavage sites key functional residues of tmprss his ser and ser were found to interact with immediate flanking residues of cleavage sites of sars cov spike protein compared to the n terminal cleavage site arg ser tmprss region that interact with c terminal cleavage site arg ser of the sars cov spike protein was predicted as relatively more druggable in summary the present study provide structural characteristics of molecular complex between human tmprss and sars cov spike protein and points to the candidate drug targets that could further be exploited to direct structure base drug designing

ID: ebbzx8yr,
Text: a cryptic site of vulnerability on the receptor binding domain of the sars cov spike glycoprotein sars cov is a zoonotic virus that has caused a pandemic of severe respiratory disease covid within several months of its initial identification comparable to the first sars cov this novel coronavirus s surface spike s glycoprotein mediates cell entry via the human ace receptor and thus is the principal target for the development of vaccines and immunotherapeutics molecular information on the sars cov s glycoprotein remains limited here we report the crystal structure of the sars cov s receptor binding domain rbd at a the highest resolution to date of å we identified a set of sars reactive monoclonal antibodies with cross reactivity to sars cov rbd and other betacoronavirus s glycoproteins one of these antibodies cr was previously shown to synergize with antibodies that target the ace binding site on the sars cov rbd and reduce viral escape capacity we determined the structure of cr in complex with the sars cov rbd and defined a broadly reactive epitope that is highly conserved across betacoronaviruses this epitope is inaccessible in the closed prefusion s structure but is accessible in open conformations this first ever resolution of a human antibody in complex with sars cov and the broad reactivity of this set of antibodies to a conserved betacoronavirus epitope will allow antigenic assessment of vaccine candidates and provide a framework for accelerated vaccine immunotherapeutic and diagnostic strategies against sars cov and related betacoronaviruses highlights high resolution structure of the sars cov receptor binding domain rbd recognition of the sars cov rbd by sars cov antibodies structure of the sars cov rbd in complex with antibody cr identification of a cryptic site of vulnerability on the sars cov spike

ID: co27h1kj,
Text: cov d a database of high resolution coronavirus protein structures the sars cov virus is the cause of the current covid pandemic and exemplifies the general threat to global health posed by coronaviruses the urgent need for effective vaccines and therapies is leading to a rapid rise in the number of high resolution structures of sars cov proteins that collectively reveal a map of virus vulnerabilities to assist structure based design of vaccines and therapeutics against sars cov and other coronaviruses we developed cov d a database and molecular viewer of sars cov and other coronavirus protein structures updated weekly cov d annotates structures of coronavirus proteins and their complexes with antibodies receptors and small molecules additionally cov d provides information on spike glycoprotein sequence variability and polymorphisms and maps these features onto the spike structure in the integrated molecular viewer in order to further aid structure based design and analysis cov d includes viewable and downloadable spike glycoprotein structures with modeled glycosylation from rosetta cov d is available at https cov d ibbr umd edu

ID: nq16jcs9,
Text: a glycan cluster on the sars cov spike ectodomain is recognized by fab dimerized glycan reactive antibodies the covid pandemic caused by sars cov has escalated into a global crisis the spike s protein that mediates cell entry and membrane fusion is the current focus of vaccine and therapeutic antibody development efforts the s protein like many other viral fusion proteins such as hiv envelope env and influenza hemagglutinin is glycosylated with both complex and high mannose glycans here we demonstrate binding to the sars cov s protein by a category of fab dimerized glycan reactive fdg hiv induced broadly neutralizing antibodies bnabs a å resolution cryo em structure of the s protein ectodomain bound to glycan dependent hiv bnab g revealed a quaternary glycan epitope on the spike s domain involving multiple protomers these data reveal a new epitope on the sars cov spike that can be targeted for vaccine design highlights fab dimerized glycan reactive fdg hiv bnabs cross react with sars cov spike å resolution cryo em structure reveals quaternary s epitope for hiv bnab g g targets glycans at positions and in the sars cov spike our studies suggest a common epitope for fdg antibodies centered around glycan

ID: jfq7820g,
Text: solution structure of the severe acute respiratory syndrome coronavirus heptad repeat domain in the prefusion state the envelope glycoprotein termed the spike protein of severe acute respiratory syndrome coronavirus sars cov is known to mediate viral entry similar to other class viral fusion proteins the heptad repeat regions of sars cov spike are thought to undergo conformational changes from a prefusion form to a subsequent post fusion form that enables fusion of the viral and host membranes recently the structure of a post fusion form of sars cov spike which consists of isolated domains of heptad repeats and hr and hr has been determined by x ray crystallography to date there is no structural information for the prefusion conformations of sars cov hr and hr in this work we present the nmr structure of the hr domain residues from sars cov termed s hr in the presence of the co solvent trifluoroethanol we find that in the absence of hr s hr forms a coiled coil symmetric trimer with a complex molecular mass of kda the s hr structure which is the first example of the prefusion form of coronavirus envelope supports the current model of viral membrane fusion and gives insight into the design of structure based antagonists of sars

ID: u17891v3,
Text: structure based design with tag based purification and in process biotinylation enable streamlined development of sars cov spike molecular probes biotin labeled molecular probes comprising specific regions of the sars cov spike would be helpful in the isolation and characterization of antibodies targeting this recently emerged pathogen to develop such probes we designed constructs incorporating an n terminal purification tag a site specific protease cleavage site the probe region of interest and a c terminal sequence targeted by biotin ligase probe regions included full length spike ectodomain as well as various subregions and we also designed mutants to eliminate recognition of the ace receptor yields of biotin labeled probes from transient transfection ranged from mg l for the complete ectodomain to mg l for several subregions probes were characterized for antigenicity and ace recognition and the structure of the spike ectodomain probe was determined by cryo electron microscopy we also characterized antibody binding specificities and cell sorting capabilities of the biotinylated probes altogether structure based design coupled to efficient purification and biotinylation processes can thus enable streamlined development of sars cov spike ectodomain probes

ID: h2zpl0qt,
Text: structure of the sars cov spike receptor binding domain bound to the ace receptor a novel and highly pathogenic coronavirus sars cov has caused an outbreak in wuhan city hubei province of china since december and soon spread nationwide and spilled over to other countries around the world to better understand the initial step of infection at an atomic level we determined the crystal structure of the sars cov spike receptor binding domain rbd bound to the cell receptor ace at å resolution the overall ace binding mode of the sars cov rbd is nearly identical to that of the sars cov rbd which also utilizes ace as the cell receptor structural analysis identified residues in the sars cov rbd that are critical for ace binding the majority of which either are highly conserved or share similar side chain properties with those in the sars cov rbd such similarity in structure and sequence strongly argue for convergent evolution between the sars cov and sars cov rbds for improved binding to ace although sars cov does not cluster within sars and sars related coronaviruses the epitopes of two sars cov antibodies targeting the rbd are also analysed with the sars cov rbd providing insights into the future identification of cross reactive antibodies

ID: sqz8yc7b,
Text: neutralization of sars cov by destruction of the prefusion spike there are as yet no licenced therapeutics for the covid pandemic the causal coronavirus sars cov binds host cells via a trimeric spike whose receptor binding domain rbd recognizes angiotensin converting enzyme ace initiating conformational changes that drive membrane fusion we find that monoclonal antibody cr binds the rbd tightly neutralising sars cov and report the crystal structure at å of the fab rbd complex some crystals are suitable for screening for entry blocking inhibitors the highly conserved structure stabilising cr epitope is inaccessible in the prefusion spike suggesting that cr binding would facilitate conversion to the fusion incompetent post fusion state cryo em analysis confirms that incubation of spike with cr fab leads to destruction of the prefusion trimer presentation of this cryptic epitope in an rbd based vaccine might advantageously focus immune responses binders at this epitope may be useful therapeutically possibly in synergy with an antibody blocking receptor attachment highlights cr neutralises sars cov neutralisation is by destroying the prefusion spike conformation this antibody may have therapeutic potential alone or with one blocking receptor attachment

ID: awyln0kk,
Text: the d structure analysis of sars cov s protein reveals a link to influenza virus neuraminidase and implications for drug and antibody discovery abstract the spike protein of sars associated coronavirus sars cov is an important target for anti sars drug discovery its s domain is responsible for receptor binding and sars cov entry into cells in this study we constructed a rational d model for s domain of sars cov spike protein by fold recognition and molecular modeling techniques we found that there is a structure similarity between s protein and influenza virus neuraminidase our analyses suggest that the existing anti influenza virus inhibitors and anti neuraminidase antibody could be used as a starting point for designing anti sars drugs vaccines and antibodies interestingly our prediction for antibody is consistent with a recently experimental discovery of anti sars antibody

ID: pjzaw7bq,
Text: neutralization of sars cov by destruction of the prefusion spike there are as yet no licensed therapeutics for the covid pandemic the causal coronavirus sars cov binds host cells via a trimeric spike whose receptor binding domain rbd recognizes angiotensin converting enzyme initiating conformational changes that drive membrane fusion we find that the monoclonal antibody cr binds the rbd tightly neutralizing sars cov and report the crystal structure at å of the fab rbd complex some crystals are suitable for screening for entry blocking inhibitors the highly conserved structure stabilizing cr epitope is inaccessible in the prefusion spike suggesting that cr binding facilitates conversion to the fusion incompetent post fusion state cryogenic electron microscopy cryo em analysis confirms that incubation of spike with cr fab leads to destruction of the prefusion trimer presentation of this cryptic epitope in an rbd based vaccine might advantageously focus immune responses binders at this epitope could be useful therapeutically possibly in synergy with an antibody that blocks receptor attachment

ID: ngg4wsa2,
Text: neutralisation of sars cov by destruction of the prefusion spike summary there are as yet no licenced therapeutics for the covid pandemic the causal coronavirus sars cov binds host cells via a trimeric spike whose receptor binding domain rbd recognises angiotensin converting enzyme ace initiating conformational changes that drive membrane fusion we find that the monoclonal antibody cr binds the rbd tightly neutralising sars cov and report the crystal structure at å of the fab rbd complex some crystals are suitable for screening for entry blocking inhibitors the highly conserved structure stabilising cr epitope is inaccessible in the prefusion spike suggesting that cr binding facilitates conversion to the fusion incompetent post fusion state cryo em analysis confirms that incubation of spike with cr fab leads to destruction of the prefusion trimer presentation of this cryptic epitope in an rbd based vaccine might advantageously focus immune responses binders at this epitope may be useful therapeutically possibly in synergy with an antibody blocking receptor attachment

ID: m3j0kv0t,
Text: structure of the sars cov spike receptor binding domain bound to the ace receptor a new and highly pathogenic coronavirus severe acute respiratory syndrome coronavirus sars cov caused an outbreak in wuhan city hubei province china starting from december that quickly spread nationwide and to other countries around the world here to better understand the initial step of infection at an atomic level we determined the crystal structure of the receptor binding domain rbd of the spike protein of sars cov bound to the cell receptor ace the overall ace binding mode of the sars cov rbd is nearly identical to that of the sars cov rbd which also uses ace as the cell receptor structural analysis identified residues in the sars cov rbd that are essential for ace binding the majority of which either are highly conserved or share similar side chain properties with those in the sars cov rbd such similarity in structure and sequence strongly indicate convergent evolution between the sars cov and sars cov rbds for improved binding to ace although sars cov does not cluster within sars and sars related coronaviruses the epitopes of two sars cov antibodies that target the rbd are also analysed for binding to the sars cov rbd providing insights into the future identification of cross reactive antibodies

ID: 908d8bax,
Text: blocking coronavirus infection via the sars cov spike protein initial steps image see text recent crystal structure data for protein protein interactions featuring the sars cov spike protein will inevitably trigger a new wave of research in this area that was not possible before this viewpoint outlines a few of the ways that it is already happening

ID: t0cw7l2a,
Text: morphology genome organization replication and pathogenesis of severe acute respiratory syndrome coronavirus sars cov sars cov is a single stranded rna virus of kb genome size which belongs to genus coronavirus and family coronaviridae sars cov has recently emerged and has been declared as a pandemic by the world health organization genomic characterization of sars cov has shown that it is of zoonotic origin the structure of sars cov is found to be similar to sars cov with virion size ranging from to nm spike membrane and envelope surface viral proteins of coronavirus are embedded in host membrane derived lipid bilayer encapsulating the helical nucleocapsid comprising viral rna the genome comprises of open reading frames orfs with and flanking untranslated regions utrs sequence variation among sars cov and sars cov revealed no significant difference in orfs and nsps the nsps includes two viral cysteine proteases including papain like protease nsp chymotrypsin like c like or main protease nsp rna dependent rna polymerase nsp helicase nsp and others likely to be involved in the transcription and replication of sars cov the structure of spike glycoprotein structure of sars cov resembles that of the spike protein of sars cov with an root mean square deviation rmsd of å like sars cov sars cov uses the ace receptor for internalization and tmprss serine proteases for s protein priming histopathological investigation of tissues from sars cov infected patients showed virus induced cytopathic effect with signs of acute respiratory distress syndrome in lung cells this chapter discusses about the morphology genome organization replication and pathogenesis of sars cov that may help us understand the disease that may leads to identification of effective antiviral drugs and vaccines

ID: nhq0oq8y,
Text: sars cov and sars cov spike rbd structure and receptor binding comparison and potential implications on neutralizing antibody and vaccine development sars cov and sars cov share a common human receptor ace protein protein interaction structure modeling indicates that spike rbd of the two viruses also has similar overall binding conformation and binding free energy to ace in vitro assays using recombinant ace proteins and ace expressing cells confirmed the two coronaviruses similar binding affinities to ace the above studies provide experimental supporting evidences and possible explanation for the high transmissibility observed in the sars cov outbreak potent ace blocking sars cov neutralizing antibodies showed limited cross binding and neutralizing activities to sars cov ace non blocking sars cov rbd antibodies though with weaker neutralizing activities against sars cov showed positive cross neutralizing activities to sars cov with an unknown mechanism these findings suggest a trade off between the efficacy and spectrum for therapeutic antibodies to different coronaviruses and hence highlight the possibilities and challenges in developing broadly protecting antibodies and vaccines against sars cov and its future mutants

ID: ratbgibg,
Text: structures of human antibodies bound to sars cov spike reveal common epitopes and recurrent features of antibodies summary neutralizing antibody responses to coronaviruses mainly target the receptor binding domain rbd of the trimeric spike here we characterized polyclonal iggs and fabs from covid convalescent individuals for recognition of coronavirus spikes plasma iggs differed in their focus on rbd epitopes recognition of alpha and beta coronaviruses and contributions of avidity to increased binding neutralization of iggs over fabs using electron microscopy we examined specificities of polyclonal plasma fabs revealing recognition of both s a and rbd epitopes on sars cov spike moreover a å cryo em structure of a neutralizing monoclonal fab spike complex revealed an epitope that blocks ace receptor binding modeling based on these structures suggested different potentials for inter spike crosslinking by iggs on viruses and that characterized iggs would not be affected by identified sars cov spike mutations overall our studies structurally define a recurrent anti sars cov antibody class derived from vh vh and similarity to a sars cov vh antibody providing criteria for evaluating vaccine elicited antibodies

ID: 2bz78yl1,
Text: considerations around the sars cov spike protein with particular attention to covid brain infection and neurological symptoms spike protein s protein is the virus key to infect cells being able to strongly bind to the human angiotensin converting enzyme ace as it has been reported in fact spike structure and function is known to be highly important for cell infection as well as entering the brain growing evidence indicates that different types of coronaviruses not only affect the respiratory system but they might also invade the central nervous system cns however very few evidence have been so far reported on the presence of covid in the brain and the potential exploitation by this virus of lung to brain axis to reach neurons has not completely understood in this article we assessed the sars cov and sars cov spike protein sequence structure and electrostatic potential using computational approaches our results showed that the s proteins of sars cov and sars cov are highly similar sharing a sequence identity of in addition we found that the sars cov s protein is slightly more positively charged than that of sars cov since it contains four more positively charged residues and five less negatively charged residues which may lead to an increased affinity to bind to negatively charged regions of other molecules through non specific and specific interactions analyzing of the s protein binds to the host ace receptor showed a higher binding energy for sars cov than the sars cov s protein these results might be useful for understanding the mechanism of cell entry blood brain barrier crossing and clinical features related to the cns infection by sars cov

ID: t4bqmgcl,
Text: considerations around the sars cov spike protein with particular attention to covid brain infection and neurological symptoms spike protein s protein is the virus key to infect cells being able to strongly bind to the human angiotensin converting enzyme ace as it has been reported in fact spike structure and function is known to be highly important for cell infection as well as entering the brain growing evidence indicates that different types of coronaviruses not only affect the respiratory system but they might also invade the central nervous system cns however very few evidence have been so far reported on the presence of covid in the brain and the potential exploitation by this virus of lung to brain axis to reach neurons has not completely understood in this article we assessed the sars cov and sars cov spike protein sequence structure and electrostatic potential using computational approaches our results showed that the s proteins of sars cov and sars cov are highly similar sharing a sequence identity of in addition we found that the sars cov s protein is slightly more positively charged than that of sars cov since it contains four more positively charged residues and five less negatively charged residues which may lead to an increased affinity to bind to negatively charged regions of other molecules through non specific and specific interactions analyzing of the s protein binds to the host ace receptor showed a higher binding energy for sars cov than the sars cov s protein these results might be useful for understanding the mechanism of cell entry blood brain barrier crossing and clinical features related to the cns infection by sars cov

ID: 4nfxdppt,
Text: structural variations in human ace may influence its binding with sars cov spike protein the recent pandemic of covid caused by sars cov is unarguably the most fearsome compared with the earlier outbreaks caused by other coronaviruses sars cov and mers cov human ace is now established as a receptor for the sars cov spike protein where variations in the viral spike protein in turn lead to the cross species transmission of the virus genetic variations in the host receptor ace may also contribute to the susceptibility and or resistance against the viral infection this study aims to explore the binding of the proteins encoded by different human ace allelic variants with sars cov spike protein briefly coding variants of ace corresponding to the reported binding sites for its attachment with coronavirus spike protein were selected and molecular models of these variants were constructed by homology modeling the models were then superimposed over the native ace and ace spike protein complex to observe structural changes in the ace variants and their intermolecular interactions with sars cov spike protein respectively despite strong overall structural similarities the spatial orientation of the key interacting residues varies in the ace variants compared with the wild type molecule most ace variants showed a similar binding affinity for sars cov spike protein as observed in the complex structure of wild type ace and sars cov spike protein however ace alleles rs s p and rs e g showed noticeable variations in their intermolecular interactions with the viral spike protein in summary our data provide a structural basis of potential resistance against sars cov infection driven by ace allelic variants

ID: m0w0fl2u,
Text: structural variations in human ace may influence its binding with sars cov spike protein the recent pandemic of covid caused by sars cov is unarguably the most fearsome compared with the earlier outbreaks caused by other coronaviruses sars cov and mers cov human ace is now established as a receptor for the sars cov spike protein where variations in the viral spike protein in turn lead to the cross species transmission of the virus genetic variations in the host receptor ace may also contribute to the susceptibility and or resistance against the viral infection this study aims to explore the binding of the proteins encoded by different human ace allelic variants with sars cov spike protein briefly coding variants of ace corresponding to the reported binding sites for its attachment with coronavirus spike protein were selected and molecular models of these variants were constructed by homology modeling the models were then superimposed over the native ace and ace spike protein complex to observe structural changes in the ace variants and their intermolecular interactions with sars cov spike protein respectively despite strong overall structural similarities the spatial orientation of the key interacting residues varies in the ace variants compared with the wild type molecule most ace variants showed a similar binding affinity for sars cov spike protein as observed in the complex structure of wild type ace and sars cov spike protein however ace alleles rs s p and rs e g showed noticeable variations in their intermolecular interactions with the viral spike protein in summary our data provide a structural basis of potential resistance against sars cov infection driven by ace allelic variants

ID: ei3kkp30,
Text: arbidol a potential antiviral drug for the treatment of sars cov by blocking the trimerization of viral spike glycoprotein abstract the sars cov pandemic is an urgent global public health emergency and warrants investigating studies on bonafide antivirals for combat here we report the drug target and mechanism of action of potential antiviral drug arbidol for sars cov infections our structural and molecular dynamics studies show how arbidol targets the sars cov spike glycoprotein and impede the trimerization of spike glycoprotein which is a key for host cell adhesion and hijacking thus placing arbidol as a potential drug for repurposing this study also abets in the development of other new therapeutics for coivd disease based on arbidol binding mode and using structure guided drug designing

ID: ct1y9amm,
Text: human neutralizing antibodies to sars cov views and perspectives from professor linqi zhang at tsinghua university professor linqi zhang s laboratory has uncovered the structure of sars cov spike receptor binding domain binding with cell receptor angiotensin converting enzyme and isolated more than receptor binding domain specific monoclonal antibodies against sars cov the top sars cov neutralizing antibodies are now under development with partnership in pharmaceutical industry

ID: d4yidznm,
Text: targeting the sars cov spike glycoprotein prefusion conformation virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors the emergence of the severe acute respiratory syndrome coronavirus sars cov has led to a renewed interest in studying the role of the spike s glycoprotein in regulating coronavirus infections in the natural host taking advantage of the cryo electron microscopy structure of sars cov s trimer in the prefusion conformation we performed a virtual screening simulation with the aim to identify novel molecules that could be used as fusion inhibitors the spike glycoprotein structure has been completed using modeling techniques and its inner cavity needful for the postfusion transition of the trimer has been scanned for the identification of strongly interacting available drugs finally the stability of the protein drug top complexes has been tested using classical molecular dynamics simulations the free energy of interaction of the molecules to the spike protein has been evaluated through the mm gbsa method and per residue decomposition analysis results have been critically discussed considering previous scientific knowledge concerning the selected compounds and sequence alignments have been carried out to evaluate the spike glycoprotein similarity among the betacoronavirus family members finally a cocktail of drugs that may be used as sars cov fusion inhibitors has been suggested

ID: g28eq99t,
Text: cryo em structure of the sars coronavirus spike glycoprotein in complex with its host cell receptor ace the trimeric sars coronavirus sars cov surface spike s glycoprotein consisting of three s s heterodimers binds the cellular receptor angiotensin converting enzyme ace and mediates fusion of the viral and cellular membranes through a pre to postfusion conformation transition here we report the structure of the sars cov s glycoprotein in complex with its host cell receptor ace revealed by cryo electron microscopy cryo em the complex structure shows that only one receptor binding domain of the trimeric s glycoprotein binds ace and adopts a protruding up conformation in addition we studied the structures of the sars cov s glycoprotein and its complexes with ace in different in vitro conditions which may mimic different conformational states of the s glycoprotein during virus entry disassociation of the s ace complex from some of the prefusion spikes was observed and characterized we also characterized the rosette like structures of the clustered sars cov s trimers in the postfusion state observed on electron micrographs structural comparisons suggested that the sars cov s glycoprotein retains a prefusion architecture after trypsin cleavage into the s and s subunits and acidic ph treatment however binding to the receptor opens up the receptor binding domain of s which could promote the release of the s ace complex and s monomers from the prefusion spike and trigger the pre to postfusion conformational transition

ID: v8fgc365,
Text: structures of human antibodies bound to sars cov spike reveal common epitopes and recurrent features of antibodies neutralizing antibody responses to coronaviruses mainly target the receptor binding domain rbd of the trimeric spike here we characterized polyclonal immunoglobulin gs iggs and fabs from covid convalescent individuals for recognition of coronavirus spikes plasma iggs differed in their focus on rbd epitopes recognition of alpha and beta coronaviruses and contributions of avidity to increased binding neutralization of iggs over fabs using electron microscopy we examined specificities of polyclonal plasma fabs revealing recognition of both s a and rbd epitopes on sars cov spike moreover a å cryo electron microscopy cryo em structure of a neutralizing monoclonal fab spike complex revealed an epitope that blocks ace receptor binding modeling based on these structures suggested different potentials for inter spike crosslinking by iggs on viruses and characterized iggs would not be affected by identified sars cov spike mutations overall our studies structurally define a recurrent anti sars cov antibody class derived from vh vh and similarity to a sars cov vh antibody providing criteria for evaluating vaccine elicited antibodies

ID: qe3f9e9a,
Text: structures of human antibodies bound to sars cov spike reveal common epitopes and recurrent features of antibodies neutralizing antibody responses to coronaviruses focus on the trimeric spike with most against the receptor binding domain rbd here we characterized polyclonal iggs and fabs from covid convalescent individuals for recognition of coronavirus spikes plasma iggs differed in their degree of focus on rbd epitopes recognition of sars cov mers cov and mild coronaviruses and how avidity effects contributed to increased binding neutralization of iggs over fabs electron microscopy reconstructions of polyclonal plasma fab spike complexes showed recognition of both s a and rbd epitopes a å cryo em structure of a neutralizing monoclonal fab s complex revealed an epitope that blocks ace receptor binding on up rbds modeling suggested that iggs targeting these sites have different potentials for inter spike crosslinking on viruses and would not be greatly affected by identified sars cov spike mutations these studies structurally define a recurrent anti sars cov antibody class derived from vh vh and similarity to a sars cov vh antibody providing criteria for evaluating vaccine elicited antibodies

ID: n9rwixr4,
Text: evolutionary relationships and sequence structure determinants in human sars coronavirus spike proteins for host receptor recognition coronavirus disease covid is a pandemic infectious disease caused by novel severe acute respiratory syndrome coronavirus sars cov the sars cov is transmitted more rapidly and readily than sars cov both sars cov and sars cov via their glycosylated spike proteins recognize the human angiotensin converting enzyme ace receptor we generated multiple sequence alignments and phylogenetic trees for representative spike proteins of sars cov and sars cov from various host sources in order to analyze the specificity in sars cov spike proteins required for causing infection in humans our results show that among the genomes analyzed two sequence regions in the n terminal domain mesefr and syltpg are specific to human sars cov in the receptor binding domain two sequence regions vggny and eiyqagstpcngv and a disulfide bridge connecting c and c in the extended loop are structural determinants for the recognition of human ace receptor the complete genome analysis of representative sars covs from bat civet human host sources and human sars cov identified the bat genome genbank code mn as closest to the recent novel human sars cov genomes the bat sars cov genomes genbank codes mg and mg are evolutionary intermediates in the mutagenesis progression toward becoming human sars cov

ID: 1dxu14b1,
Text: evolutionary relationships and sequence structure determinants in human sars coronavirus spike proteins for host receptor recognition coronavirus disease covid is a pandemic infectious disease caused by novel severe acute respiratory syndrome coronavirus sars cov the sars cov is transmitted more rapidly and readily than sars cov both sars cov and sars cov via their glycosylated spike proteins recognize the human angiotensin converting enzyme ace receptor we generated multiple sequence alignments and phylogenetic trees for representative spike proteins of sars cov and sars cov from various host sources in order to analyze the specificity in sars cov spike proteins required for causing infection in humans our results show that among the genomes analysed two sequence regions in the n terminal domain ntd mesefr and syltpg are specific to human sars cov in the receptor binding domain rbd two sequence regions vggny and eiyqagstpcngv and a disulfide bridge connecting c and c in the extended loop are structural determinants for the recognition of human ace receptor the complete genome analysis of representative sars covs from bat civet human host sources and human sars cov identified the bat genome genbank code mn as closest to the recent novel human sars cov genomes the bat sars cov genomes genbank codes mg and mg are evolutionary intermediates in the mutagenesis progression towards becoming human sars cov this article is protected by copyright all rights reserved

ID: c5fygzvz,
Text: exploring the genomic and proteomic variations of sars cov spike glycoprotein a computational biology approach the newly identified sars cov has now been reported from around countries with more than a million confirmed human cases including more than deaths the genomes of sars cov strains isolated from different parts of the world are now available and the unique features of constituent genes and proteins need to be explored to understand the biology of the virus spike glycoprotein is one of the major targets to be explored because of its role during the entry of coronaviruses into host cells we analyzed whole genome sequences and spike protein sequences of sars cov using multiple sequence alignment in this study unique variations have been identified among the genomes of sars cov including nonsynonymous mutations and one deletion in the spike s protein among the variations detected in s variations were located at the n terminal domain ntd and variations at the receptor binding domain rbd which might alter the interaction of s protein with the host receptor angiotensin converting enzyme ace besides amino acid insertions were identified in the spike protein of sars cov in comparison with that of sars cov phylogenetic analyses of spike protein revealed that bat coronavirus have a close evolutionary relationship with circulating sars cov the genetic variation analysis data presented in this study can help a better understanding of sars cov pathogenesis based on results reported herein potential inhibitors against s protein can be designed by considering these variations and their impact on protein structure

ID: w5ytp1q7,
Text: exploring the genomic and proteomic variations of sars cov spike glycoprotein a computational biology approach the newly identified sars cov has now been reported from around countries with more than a million confirmed human cases including more than deaths the genomes of sars cov strains isolated from different parts of the world are now available and the unique features of constituent genes and proteins need to be explored to understand the biology of the virus spike glycoprotein is one of the major targets to be explored because of its role during the entry of coronaviruses into host cells we analyzed whole genome sequences and spike protein sequences of sars cov using multiple sequence alignment in this study unique variations have been identified among the genomes of sars cov including nonsynonymous mutations and one deletion in the spike s protein among the variations detected variations were located at the n terminal domain and variations at the receptor binding domain rbd which might alter the interaction of s protein with the host receptor angiotensin converting enzyme ace besides amino acid insertions were identified in the spike protein of sars cov in comparison with that of sars cov phylogenetic analyses of spike protein revealed that bat coronavirus have a close evolutionary relationship with circulating sars cov the genetic variation analysis data presented in this study can help a better understanding of sars cov pathogenesis based on results reported herein potential inhibitors against s protein can be designed by considering these variations and their impact on protein structure

ID: hmswnrgg,
Text: structure of sars coronavirus spike receptor binding domain complexed with receptor the spike protein s of sars coronavirus sars cov attaches the virus to its cellular receptor angiotensin converting enzyme ace a defined receptor binding domain rbd on s mediates this interaction the crystal structure at angstrom resolution of the rbd bound with the peptidase domain of human ace shows that the rbd presents a gently concave surface which cradles the n terminal lobe of the peptidase the atomic details at the interface between the two proteins clarify the importance of residue changes that facilitate efficient cross species infection and human to human transmission the structure of the rbd suggests ways to make truncated disulfide stabilized rbd variants for use in the design of coronavirus vaccines

ID: yaow639d,
Text: structure function and antigenicity of the sars cov spike glycoprotein the recent emergence of a novel coronavirus associated with an ongoing outbreak of pneumonia covid resulted in infections of more than people and claimed over lives coronavirus spike s glycoprotein trimers promote entry into cells and are the main target of the humoral immune response we show here that sars cov s mediates entry in veroe cells and in bhk cells transiently transfected with human ace establishing ace as a functional receptor for this novel coronavirus we further demonstrate that the receptor binding domains of sars cov s and sars cov s bind with similar affinities to human ace which correlates with the efficient spread of sars cov among humans we found that the sars cov s glycoprotein harbors a furin cleavage site at the boundary between the s s subunits which is processed during biogenesis and sets this virus apart from sars cov and other sars related covs we determined a cryo electron microscopy structure of the sars cov s ectodomain trimer demonstrating spontaneous opening of the receptor binding domain and providing a blueprint for the design of vaccines and inhibitors of viral entry finally we demonstrate that sars cov s murine polyclonal sera potently inhibited sars cov s mediated entry into target cells thereby indicating that cross neutralizing antibodies targeting conserved s epitopes can be elicited upon vaccination

ID: 50hqr249,
Text: gene of the month the ncov sars cov novel coronavirus spike protein the year has seen a major and sustained outbreak of a novel betacoronavirus severe acute respiratory syndrome sars coronavirus cov infection that causes fever severe respiratory illness and pneumonia a disease called covid at the time of writing the death toll was greater than worldwide with more than million documented infections the genome of the cov encodes a number of structural proteins that facilitate cellular entry and assembly of virions of which the spike protein s appears to be critical for cellular entry the spike protein guides the virus to attach to the host cell the spike protein contains a receptor binding domain rbd a fusion domain and a transmembrane domain the rbd of spike protein s binds to angiotensin converting enzyme ace to initiate cellular entry the spike protein of sars cov shows more than amino acid similarity to the pangolin and bat covs and these also use ace as a receptor binding of the spike protein to ace exposes the cleavage sites to cellular proteases cleavage of the spike protein by transmembrane protease serine and other cellular proteases initiates fusion and endocytosis the spike protein contains an addition furin cleavage site that may allow it to be preactivated and highly infectious after replication the fundamental role of the spike protein in infectivity suggests that it is an important target for vaccine development blocking therapy with antibodies and diagnostic antigen based tests this review briefly outlines the structure and function of the novel cov sars cov spike protein s

ID: tpn5cg4n,
Text: architecture of the sars coronavirus prefusion spike the emergence in of a new coronavirus cov responsible for the atypical pneumonia termed severe acute respiratory syndrome sars was a stark reminder that hitherto unknown viruses have the potential to cross species barriers to become new human pathogens here we describe the sars cov spike structure determined by single particle cryo em along with the docked atomic structures of the receptor binding domain and prefusion core supplementary information the online version of this article doi nsmb contains supplementary material which is available to authorized users

ID: 40ejbv5j,
Text: gene of the month the ncov sars cov novel coronavirus spike protein the year has seen a major and sustained outbreak of a novel betacoronavirus severe acute respiratory syndrome sars coronavirus cov infection that causes fever severe respiratory illness and pneumonia a disease called covid at the time of writing the death toll was greater than worldwide with more than million documented infections the genome of the cov encodes a number of structural proteins that facilitate cellular entry and assembly of virions of which the spike protein s appears to be critical for cellular entry the spike protein guides the virus to attach to the host cell the spike protein contains a receptor binding domain rbd a fusion domain and a transmembrane domain the rbd of spike protein s binds to angiotensin converting enzyme ace to initiate cellular entry the spike protein of sars cov shows more than amino acid similarity to the pangolin and bat covs and these also use ace as a receptor binding of the spike protein to ace exposes the cleavage sites to cellular proteases cleavage of the spike protein by transmembrane protease serine and other cellular proteases initiates fusion and endocytosis the spike protein contains an addition furin cleavage site that may allow it to be preactivated and highly infectious after replication the fundamental role of the spike protein in infectivity suggests that it is an important target for vaccine development blocking therapy with antibodies and diagnostic antigen based tests this review briefly outlines the structure and function of the novel cov sars cov spike protein s

ID: erdity4m,
Text: cryo electron microscopy structure of the sads cov spike glycoprotein provides insights into an evolution of unique coronavirus spike proteins the outbreak of a novel betacoronavirus sars cov has aroused great public health concern as a new coronavirus which was responsible for a large scale outbreak of fatal disease in piglets in china swine acute diarrhea syndrome coronavirus sads cov originated from the same genus of horseshoe bats rhinolophus as sars cov and possesses a broad species tropism in addition to human cells it can also infect cell lines from diverse species given the importance of the spike glycoprotein s protein in viral entry and host immune responses here we report the cryo em structure of the sads cov s in the prefusion conformation at a resolution of å our studies reveal that sads cov s structure takes an intra subunit quaternary packing mode where the ntd and ctd from the same subunit pack together by facing each other the comparison of ntd and ctd with that of the other four genera gives the suggestion of the evolutionary procedure of the sads cov s moreover sads cov s has several characteristic structural features i e more compact architecture of s trimer masking of epitopes by glycan shielding which may facilitate to viral immune evasion these data provide new insights into the evolutionary relationships of sads cov s and would deepen our understanding of their structural and functional diversity which will facilitate to vaccine development

ID: nubewu46,
Text: a neutralizing human antibody binds to the n terminal domain of the spike protein of sars cov developing therapeutics against sars cov could be guided by the distribution of epitopes not only on the receptor binding domain rbd of the spike s protein but also across the full spike s protein we isolated and characterized monoclonal antibodies mabs from ten convalescent covid patients three mabs showed neutralizing activities against authentic sars cov an mab named a exhibits high neutralization potency against both authentic and pseudotyped sars cov but does not bind the rbd we defined the epitope of a as the n terminal domain ntd of the s protein by determining its cryo em structure in complex with the s protein to an overall resolution of angstrom and local resolution of angstrom for the a ntd interface this points to the ntd as a promising target for therapeutic mabs against covid

ID: im2np7s1,
Text: structure function and antigenicity of the sars cov spike glycoprotein the emergence of sars cov has resulted in infections and deaths coronavirus spike s glycoproteins promote entry into cells and are the main target of antibodies we show that sars cov s uses ace to enter cells and that the receptor binding domains of sars cov s and sars cov s bind with similar affinities to human ace correlating with the efficient spread of sars cov among humans we found that the sars cov s glycoprotein harbors a furin cleavage site at the boundary between the s s subunits which is processed during biogenesis and sets this virus apart from sars cov and sars related covs we determined cryo em structures of the sars cov s ectodomain trimer providing a blueprint for the design of vaccines and inhibitors of viral entry finally we demonstrate that sars cov s murine polyclonal antibodies potently inhibited sars cov s mediated entry into cells indicating that cross neutralizing antibodies targeting conserved s epitopes can be elicited upon vaccination

ID: srgi9jc6,
Text: sars cov mutations and where to find them an in silico perspective of structural changes and antigenicity of the spike protein the recent emergence of a novel coronavirus sars cov is causing a severe global health threat characterized by severe acute respiratory syndrome covid at the moment there is no specific treatment for this disease and vaccines are still under development the structural protein spike is essential for virus infection and has been used as the main target for vaccine and serological diagnosis test development we analysed sequences of the spike protein from sars cov isolates and identified variability in amino acid residues and their worldwide distribution in all continents we used the three dimensional structure of the homo trimer model to predict conformational epitopes of b cell and sequence of spike protein wuhan hu to predict linear epitopes of t cytotoxic and t helper cells we identified epitopes with amino acid variations finally we showed the distribution of mutations within the epitopes our findings can help researches to identify more efficient strategies for the development of vaccines therapies and serological diagnostic tests based on the spike protein of sars cov

ID: 38d140wp,
Text: structural similarity between hiv gp and sars cov s proteins suggests an analogous membrane fusion mechanism abstract sars associated coronavirus sars cov has been identified as the causal agent of a new emerging disease severe acute respiratory syndrome sars its spike protein s is responsible for mediating fusion of viral and cellular membrane in this study we modeled the d structure of s subunit and compared this model with the core structure of gp from hiv we found that sars cov s and gp share the same two α helices suggesting that the two viruses could follow an analogous membrane fusion mechanism further ligand binding analysis showed that two inhibitors ggl and d peptide from hiv gp may serve as inhibitors for sars cov entry

ID: 2o8u4eny,
Text: the sars cov s glycoprotein the severe acute respiratory syndrome coronavirus sars cov spike s glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion it is also a major immunogen and a target for entry inhibitors recent rapid advances in our knowledge of the structure and function of this protein have lead to the development of a number of candidate vaccine immunogens and sars cov entry inhibitors

ID: ch004jxy,
Text: understanding the b and t cells epitopes of spike protein of severe respiratory syndrome coronavirus a computational way to predict the immunogens the novel severe respiratory syndrome coronavirus sars cov outbreak has caused a large number of deaths with thousands of confirmed cases worldwide the present study followed computational approaches to identify b and t cell epitopes for spike glycoprotein of sars cov by its interactions with the human leukocyte antigen alleles we identified twenty four peptide stretches on the sars cov spike protein that are well conserved among the reported strains the s protein structure further validated the presence of predicted peptides on the surface out of which twenty are surface exposed and predicted to have reasonable epitope binding efficiency the work could be useful for understanding the immunodominant regions in the surface protein of sars cov and could potentially help in designing some peptide based diagnostics

ID: 4skamxby,
Text: the discovery of potential natural products for targeting sars cov spike protein by virtual screening severe acute respiratory syndrome coronavirus sars cov enters into the cells through its spike proteins binding to human angiotensin converting enzyme ace protein and causes virus infection in host cells until now there are no available antiviral drugs have been reported that can effectively block virus infection the study aimed to discover the potential compounds to prevent viral spike proteins to bind to the human ace proteins from taiwan database of extracts and compounds tdec by structure based virtual screening in this study to rapidly discover potential inhibitors against sars cov spike proteins the molecular docking calculation was performed by autodock vina program herein we found that potential compounds may have good binding affinities and can respectively bind to the viral receptor binding domain rbd of spike protein in the prefusion conformation and spike ace complex protein in silico among those compounds especially natural products thioflexibilolide a and candidine that were respectively isolated from the soft corals sinularia flexibilis and phaius mishmensis may have better binding affinity than others this study provided the predictions that these compounds may have the potential to prevent sars cov spike protein from entry into cells

ID: trlni6iq,
Text: structure function and antigenicity of the sars cov spike glycoprotein the emergence of sars cov has resulted in infections and deaths coronavirus spike s glycoproteins promote entry into cells and are the main target of antibodies we show that sars cov s uses ace to enter cells and that the receptor binding domains of sars cov s and sars cov s bind with similar affinities to human ace correlating with the efficient spread of sars cov among humans we found that the sars cov s glycoprotein harbors a furin cleavage site at the boundary between the s s subunits which is processed during biogenesis and sets this virus apart from sars cov and sars related covs we determined cryo em structures of the sars cov s ectodomain trimer providing a blueprint for the design of vaccines and inhibitors of viral entry finally we demonstrate that sars cov s murine polyclonal antibodies potently inhibited sars cov s mediated entry into cells indicating that cross neutralizing antibodies targeting conserved s epitopes can be elicited upon vaccination

ID: sb297tzj,
Text: cryo em structure of the ncov spike in the prefusion conformation the outbreak of a novel coronavirus ncov represents a pandemic threat that has been declared a public health emergency of international concern the cov spike s glycoprotein is a key target for vaccines therapeutic antibodies and diagnostics to facilitate medical countermeasure development we determined a angstrom resolution cryo electron microscopy structure of the ncov s trimer in the prefusion conformation the predominant state of the trimer has one of the three receptor binding domains rbds rotated up in a receptor accessible conformation we also provide biophysical and structural evidence that the ncov s protein binds angiotensin converting enzyme ace with higher affinity than does severe acute respiratory syndrome sars cov s additionally we tested several published sars cov rbd specific monoclonal antibodies and found that they do not have appreciable binding to ncov s suggesting that antibody cross reactivity may be limited between the two rbds the structure of ncov s should enable the rapid development and evaluation of medical countermeasures to address the ongoing public health crisis

ID: prqeufwg,
Text: cryo em structure of the ncov spike in the prefusion conformation the outbreak of a novel betacoronavirus ncov represents a pandemic threat that has been declared a public health emergency of international concern the cov spike s glycoprotein is a key target for urgently needed vaccines therapeutic antibodies and diagnostics to facilitate medical countermeasure mcm development we determined a å resolution cryo em structure of the ncov s trimer in the prefusion conformation the predominant state of the trimer has one of the three receptor binding domains rbds rotated up in a receptor accessible conformation we also show biophysical and structural evidence that the ncov s binds ace with higher affinity than sars cov s additionally we tested several published sars cov rbd specific monoclonal antibodies and found that they do not have appreciable binding to ncov s suggesting antibody cross reactivity may be limited between the two virus rbds the atomic resolution structure of ncov s should enable rapid development and evaluation of mcms to address the ongoing public health crisis

ID: vp96izcs,
Text: cryo em structure of the ncov spike in the prefusion conformation the outbreak of a novel coronavirus ncov represents a pandemic threat that has been declared a public health emergency of international concern the cov spike s glycoprotein is a key target for vaccines therapeutic antibodies and diagnostics to facilitate medical countermeasure development we determined a angstrom resolution cryo electron microscopy structure of the ncov s trimer in the prefusion conformation the predominant state of the trimer has one of the three receptor binding domains rbds rotated up in a receptor accessible conformation we also provide biophysical and structural evidence that the ncov s protein binds angiotensin converting enzyme ace with higher affinity than does severe acute respiratory syndrome sars cov s additionally we tested several published sars cov rbd specific monoclonal antibodies and found that they do not have appreciable binding to ncov s suggesting that antibody cross reactivity may be limited between the two rbds the structure of ncov s should enable the rapid development and evaluation of medical countermeasures to address the ongoing public health crisis
